Alcobra Ltd.

The four board members who voted Arcturus Therapeutics Inc. founder Joseph Payne out of the RNA drug development firm at the end of January have been replaced under a settlement between the executiv

Financings Third-quarter 2017 biopharma financing reached $12.5 billion, just a 6% decrease from the previous quarter's $13.4 billion. ( See Exhibit 1. ) The most money was raised in the follow-on pub

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in

Biopharmaceutical start-up companies – firms founded four years ago or less – raised fewer dollars during the third quarter than during the prior quarter despite Roivant Sciences GMBH 's massive $1